Revvity Inc (RVTY, Financial) has recently shown a daily gain of 1.84%, yet over the past three months, the stock has experienced a slight decline of 1.57%. With an Earnings Per Share (EPS) of 5.95, investors are keen to understand: is Revvity fairly valued at its current market price? This article delves into the valuation analysis of Revvity, offering a detailed perspective for potential investors.
Company Introduction
Revvity Inc (RVTY, Financial) operates at the forefront of the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. With a focus on diagnostics, reproductive health, applied genomics, and analytical solutions, Revvity's diverse range of products and services, from genetic screening to environmental tools, positions it as a key player in its industry. At a current price of $107.71, Revvity's market cap stands at $13.30 billion, with sales reaching $2.80 billion. The comparison between the stock price and the GF Value, an estimation of the fair value, sets the stage for an in-depth valuation analysis.
Understanding GF Value
The GF Value is a proprietary metric that suggests the intrinsic value of a stock, taking into account historical trading multiples, an adjustment factor based on past performance and growth, and future business performance forecasts. This value serves as a benchmark for determining whether a stock is overvalued, undervalued, or fairly priced. Revvity's current share price hovers close to the GF Value, suggesting that the stock may be fairly valued. This alignment implies that the long-term return of Revvity's stock is likely to mirror the company's business growth rate.
Link: These companies may deliver higher future returns at reduced risk.
Financial Strength Assessment
Investors must consider a company's financial strength to avoid high risks of permanent capital loss. Revvity's cash-to-debt ratio of 0.36 places it in a less favorable position than many of its industry peers, indicating that its financial strength is fair but not exceptional. This assessment is critical when considering investment decisions.
Profitability and Growth Prospects
Consistent profitability is a hallmark of a less risky investment. Revvity has maintained profitability for the past decade, with a solid operating margin that outperforms many in its industry. The company's strong profitability and growth metrics, such as a 3-year average EBITDA growth rate of 26.5%, suggest a robust financial future. This growth is essential for creating shareholder value and should be a focal point for investors.
Evaluating ROIC vs WACC
An essential aspect of profitability is the comparison between Return on Invested Capital (ROIC) and Weighted Average Cost of Capital (WACC). Ideally, a company's ROIC should exceed its WACC, indicating efficient capital use. Revvity's ROIC of 2.21% compared to its WACC of 8.19% raises questions about its capital efficiency, which investors should carefully evaluate.
Concluding Insights on Revvity's Valuation
In conclusion, Revvity (RVTY, Financial) appears to be fairly valued in the current market. The company's financial condition is fair, and its profitability is strong. Moreover, its growth outpaces a significant portion of its industry peers. For a more detailed financial overview, interested parties can review Revvity's 30-Year Financials here.
To explore high-quality companies that may deliver above-average returns, consider using the GuruFocus High Quality Low Capex Screener.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
